LAVAL, Québec, August 27, 2025--(BUSINESS WIRE)--Altasciences, a fully integrated CRO/CDMO offering comprehensive early-phase drug development solutions, is pleased to announce a strategic ...

LAVAL, Québec, August 21, 2025--(BUSINESS WIRE)--Altasciences is pleased to have been chosen by Steel Therapeutics, Inc. ("Steel"), to initiate a pivotal toxicology study for Fizurex™, a novel topical ...

LAVAL, Quebec--(BUSINESS WIRE)--Altasciences, a trusted drug development research partner for over 30 years, continues its commitment to providing world-class bioanalytical services. This core ...

Laval, Quebec-based Altasciences has acquired WCCT Global, a Cypress, California-based early-stage clinical research organization. No financial terms were disclosed. Altasciences, a CRO specializing ...

Altasciences, a fully integrated drug development solution company, and Certara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to ...

LAVAL, Québec--(BUSINESS WIRE)--Altasciences is proud to announce that CEO Chris Perkin has been recognized as a 2019 Red Jacket honoree. The Red Jacket Award was introduced by PharmaVOICE in 2014 to ...

LAVAL, Québec--(BUSINESS WIRE)--#Biotech--Altasciences hired two expert advisors to support its strategic growth in Europe, while its preclinical team continues to expand with the addition of two key ...

LAVAL, Quebec — Altasciences today announced the completion of the acquisition of a preclinical testing business in Everett, Washington. This transaction will support Altasciences’ goal of being a mid ...